Managers / Q3 2025 · view latest →
Deuterium Capital Management, LLC
CIK 0001860487 · 1150 CLEVELAND ST, SUITE 420, CLEARWATER, FL, 33755-4860 · 727-204-7570
Summary
Deuterium Capital Management, LLC reported $69M in U.S.-listed holdings across 18 positions for Q3 2025.
The portfolio is heavily concentrated: ORCL alone accounts for 20.4% of reported value.
The book was largely unchanged from Q2 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.3% · $58M
- Other · 11.1% · $8M
- ETP · 5.6% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GOOGALPHABET INC | ADDED | +10.8K | 54.0K | +$5M | $13M |
| ORCLORACLE CORP | HELD | +0 | 50.0K | +$3M | $14M |
| PLTRPALANTIR TECHNOLOGIES INC | HELD | +0 | 67.5K | +$3M | $12M |
| IMPERIAL PETE INC | HELD | +0 | 1.60M | +$3M | $8M |
| ISRGINTUITIVE SURGICAL INC | HELD | +0 | 15.4K | −$1M | $7M |
| NKTRNEKTAR THERAPEUTICS | HELD | +0 | 37.3K | +$1M | $2M |
| ETHAISHARES ETHEREUM TR | HELD | +0 | 30.0K | +$373,200 | $945,300 |
| UECURANIUM ENERGY CORP | HELD | +0 | 41.8K | +$273,601 | $558,079 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ORCLORACLE CORPhistory → | COM | 20.35% | $14M | 50.0K |
| 2 | GOOGALPHABET INChistory → | CAP STK CL C | 19.04% | $13M | 54.0K |
| 3 | PLTRPALANTIR TECHNOLOGIES INChistory → | CL A | 17.82% | $12M | 67.5K |
| 4 | IMPERIAL PETE INC | COM NEW | 11.08% | $8M | 1.60M |
| 5 | ISRGINTUITIVE SURGICAL INChistory → | COM NEW | 9.99% | $7M | 15.4K |
| 6 | CORZCORE SCIENTIFIC INC NEWhistory → | COM | 7.79% | $5M | 300.0K |
| 7 | NKTRNEKTAR THERAPEUTICShistory → | COM NEW | 3.08% | $2M | 37.3K |
| 8 | ENVXENOVIX CORPORATIONhistory → | COM | 2.00% | $1M | 138.4K |
| 9 | URAGLOBAL X FDShistory → | GLOBAL X URANIUM | 1.87% | $1M | 27.2K |
| 10 | ETHAISHARES ETHEREUM TRhistory → | SHS | 1.37% | $945,300 | 30.0K |
| 11 | URNMSPROTT FDS TRhistory → | URANIUM MINERS E | 1.31% | $906,450 | 15.0K |
| 12 | SIRISIRIUSXM HOLDINGS INC | COMMON STOCK | 0.99% | $682,237 | 29.3K |
| 13 | UECURANIUM ENERGY CORP | COM | 0.81% | $558,079 | 41.8K |
| 14 | VALVALARIS LTD | CL A | 0.71% | $487,700 | 10.0K |
| 15 | PSCEINVESCO EXCH TRADED FD TR II | S&P SMALLCAP ENE | 0.56% | $383,588 | 9.0K |
| 16 | ETHEGRAYSCALE ETHEREUM TRUST ETF | SHS | 0.50% | $342,700 | 10.0K |
| 17 | DNNDENISON MINES CORP | COM | 0.48% | $330,668 | 120.2K |
| 18 | RIGTRANSOCEAN LTD | REGISTERED SHS | 0.27% | $187,200 | 60.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $86M | 26 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $69M | 20 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $69M | 18 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $53M | 18 | Aug 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $45M | 41 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $38M | 35 | Feb 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $55M | 38 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $59M | 55 | Jul 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $56M | 56 | May 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $30M | 53 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $42M | 61 | Oct 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $77M | 97 | Aug 11, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2023 | $64M | 90 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $38M | 65 | Feb 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $24M | 33 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $30M | 49 | Jul 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $78M | 74 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $68M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.